Diuretics for Ménière's disease or syndrome

Citations of this article
Mendeley users who have this article in their library.
Get full text


Background: This is an update of a review first published in The Cochrane Library Issue 3, 2006. Ménière's disease is a disorder characterised by hearing loss, tinnitus and disabling vertigo. Diuretics are used to try to reduce the severity and frequency of episodes but there is little evidence behind this treatment. Objectives: To assess the effect of diuretic treatment in patients with Ménière's disease. Search strategy: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE;CINAHL;Web of Science; BIOSIS Previews;Cambridge Scientific Abstracts;mRCTand additional sources for published and unpublished trials. The date of the most recent search was 16 April 2009. Selection criteria: Randomised controlled trials of diuretic versus placebo in Ménière's patients. Data collection and analysis: Search results fromthe original and update searches were screened independently. We retrieved full text of potentially relevant articles and applied the inclusion criteria. Ten studies were excluded from the review due to inappropriate study design or absence of randomisation. Main results: There were no trials of high enough quality to meet the standard set for this review. Authors' conclusions: There is insufficient good evidence of the effect of diuretics on vertigo, hearing loss, tinnitus or aural fullness in clearly defined Ménière's disease. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.




Burgess, A., & Kundu, S. (2009). Diuretics for Ménière’s disease or syndrome. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003599.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free